News of the WeekBiomedical Research

Disappointing Data Scuttle Plans for Large-Scale AIDS Vaccine Trial

See allHide authors and affiliations

Science  01 Mar 2002:
Vol. 295, Issue 5560, pp. 1616-1617
DOI: 10.1126/science.295.5560.1616

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Summary

SEATTLE, WASHINGTON-- The National Institutes of Health (NIH) has decided not to fund full-scale clinical trials of the leading AIDS vaccine in its pipeline after an interim analysis of results from a midsize human study showed weaker-than-hoped-for immune responses against HIV. Even so, the U.S. military and the makers of the vaccine, in collaboration with researchers and officials in Thailand, are still planning to go ahead with a large-scale trial of a similar preparation, and Merck is working with NIH to move another vaccine into midsize trials.